Results 51 to 60 of about 6,612 (269)
Differential diagnosis of polyneuropathies in diabetes mellitus
Diabetic polyneuropathy (DPN) is heterogeneous in its clinical course and clinical manifestations. Depending on the primary lesion of large or small nerve fibers, different onset, course and clinical manifestations of polyneuropathy are possible.
V. N. Khramilin
doaj +1 more source
This study comprises three experimental parts. Part 1. Time‐course of ouabain‐induced hearing loss. Rats received ouabain (10 mM) via round window application. ABR/DPOAE tests and histological analyses were performed at 2, 7, and 30 days post‐treatment to characterize SGN and glial cell degeneration. Part 2.
Huidong Chen +9 more
wiley +1 more source
Controlled analysis of ethiological factors in axonal idiopathic polyneuropathies [PDF]
Institutul de Neurologie şi NeurochirurgieThe axonal polyneuropathies or axonopathies can be caused by different factors, but in almost 50-60% of cases ethiological factor is not established correctly and patients with peripheral polyneuropathies are ...
Misic, Octavian
core
Comment on Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Padua, Luca, Caliandro, Pietro
core +1 more source
Monoallelic POLR3A Variants Cause Early‐Onset Peripheral Neuropathy
Objective Biallelic variants in genes encoding the RNA polymerase III complex (Pol III) cause a spectrum of neurological disorders primarily affecting the central nervous system. Monoallelic variants have been reported in the POLR3B subunit only, associated with neurodevelopmental disorder, epilepsy, and peripheral neuropathy.
Luiza L. P. Ramos +46 more
wiley +1 more source
Systemic inflammatory markers in patients with polyneuropathies
IntroductionIn patients with peripheral neuropathies (PNP), neuropathic pain is present in 50% of the cases, independent of the etiology. The pathophysiology of pain is poorly understood, and inflammatory processes have been found to be involved in neuro-
Patricia García-Fernández +9 more
doaj +1 more source
Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies [PDF]
Introduction: Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of autoimmune and systemic inflammatory diseases with both licensed and off-label indications.
Vécsei László +2 more
core +1 more source
Gephyrin Neurological Autoimmunity
Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin‐immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff‐person‐like syndrome, but its broader clinical relevance remains unknown.
Maria Chiara Pantuliano +10 more
wiley +1 more source
Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterized by eosinophilia, asthma, and ear, nose, and throat (ENT) involvement. Although glucocorticoids (GCs) are effective in controlling symptoms, relapses and GC dependence are common. The aim of this study was to develop predictive models for vasculitis
Matthias Papo +35 more
wiley +1 more source
Neuromuscular diseases in elderly [PDF]
Introduction: Even though neuromuscular diseases are not the first association in the elderly, the results of previous epidemiological studies record an increase in the incidence of acquired immune-mediated neuropathies, amyotrophic lateral sclerosis ...
Perić Stojan, Basta Ivana
doaj +1 more source

